GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CANbridge Pharmaceuticals 1228.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.69

+2.42%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

CANbridge Pharmaceuticals — daily HKEX:1228

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View CANbridge Pharmaceuticals on TradingView ↗
Market value
HK$718.0m
Last close × shares
Volume
23k
Shares, 9 Nov 2026
Price to earnings
48.7

About CANbridge Pharmaceuticals

Its shares trade on HKEX under the ticker 1228.HK. It has been listed since 10 December 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥50.0m and net income of CN¥14.8m. At that date it held total assets of CN¥165.5m and shareholders' equity of −CN¥341.9m.

CANbridge Pharmaceuticals Inc. operates as a rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2021-12-10. The firm's main businesses are the development, production, promotion and sales of medical products. The firm's main product is the glycosylated fusion protein CAN008 for the treatment of glioblastoma (GBM). The firm's products are mainly used in rare diseases such as Hunter's syndrome (MPS II), rare tumors and other fields. The firm is also engaged in the development of gene therapy.

Figures and description from our data supplier, not checked against the company's own report.

More about CANbridge Pharmaceuticals →

Latest on CANbridge Pharmaceuticals

Our reporting

Next results

1 Apr 2027

Due on 1 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is CANbridge Pharmaceuticals's ticker?

CANbridge Pharmaceuticals trades as 1228.HK on HKEX, under ISIN KYG1821D1097.

What was CANbridge Pharmaceuticals's last closing price?

1.69 on 9 Nov 2026. The figure is in HKD and is never converted.

When does CANbridge Pharmaceuticals next report results?

Results are expected on 1 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.